U.S Class(es): 005, 006, 018, 044, 046, 051, 052
Class Status: Active
| Name | Lori Wolfe Teva Pharmaceuticals USA, Inc. |
|---|---|
| Address | 400 Interpace Parkway Parsippany, NJ 07054 United States |
| Date | Description | Action Tags | Code |
|---|---|---|---|
| Oct-24-2024 | NEW APPLICATION ENTERED | NWAPI | |
| Oct-24-2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
| Mar-24-2025 | ASSIGNED TO EXAMINER | DOCKD | |
| Mar-31-2025 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAP | |
| Apr-23-2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | NONPE | |
| Apr-29-2025 | PUBLISHED FOR OPPOSITION | PUBOA | |
| Apr-29-2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | NPUBE | |
| Jun-24-2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | NOAME | |
| Jan-21-2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | REAPI | |
| Jan-21-2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | ARAAI | |
| Jan-21-2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | TCCAI | |
| Jan-26-2026 | ABANDONMENT - NO USE STATEMENT FILED | ABN6S | |
| Jan-26-2026 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | MAB6E | |
| Jan-26-2026 | TEAS PETITION TO REVIVE RECEIVED | PROAI | |
| Jan-26-2026 | PETITION TO REVIVE-GRANTED | PETGO | |
| Jan-26-2026 | NOTICE OF REVIVAL - E-MAILED | NREVE | |
| Jan-26-2026 | SOU EXTENSION RECEIVED WITH TEAS PETITION | TPEXI | |
| Mar-02-2026 | CASE ASSIGNED TO INTENT TO USE PARALEGAL | AITUA | |
| Dec-23-2025 | SOU EXTENSION 1 FILED | EXT1S | |
| Mar-03-2026 | SOU EXTENSION 1 GRANTED | EX1GS | |
| Mar-04-2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE |